Skip to main content

Table 2 Summary of mean and standard deviation (SD) for haemoglobin (Hb) and haematinics; serum ferritin and transferrin saturation (TSAT) at baseline, 1 and 3 months

From: A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status

  

FDI

Placebo

 
 

Mean

SD

n

Mean

SD

n

P value

Hb

Baseline

131.0

7.4

26

126.5

11.8

28

 

1 month

132.7

7.2

24

125.5

12.8

26

0.195

3 months

134.7

8.9

20

126.2

12.4

25

0.152

Serum Ferritin

Baseline

64.2

29.1

26

68.4

55.3

27

 

1 month

266.0

105.8

23

70.5

55.8

26

< 0.001

3 months

234.4

105.3

21

69.4

59.8

24

< 0.001

TSAT

Baseline

22.3

8.8

26

19.7

5.6

27

 

1 month

29.6

9.5

22

19.1

7.1

26

< 0.001

3 months

26.4

10.5

21

18.0

6.8

23

< 0.001

  1. There was a statistically significant difference for SF and TSAT at both 1-month (p < 0.001, p < 0.001) and 3 (p < 0.001 and p = 0.001) months, respectively, with greater increases in the FDI group (Figs. 3 and 4, Table 2)